Bosh sahifa002294 • SHE
add
Shenzhen Salubris Pharmaceuticals Co Ltd
Yopilish kursi
52,42 ¥
Kunlik diapazon
51,80 ¥ - 53,09 ¥
Yillik diapazon
29,72 ¥ - 65,63 ¥
Bozor kapitalizatsiyasi
58,41 mlrd CNY
Oʻrtacha hajm
6,13 mln
Narx/foyda
86,84
Dividend daromadliligi
0,95%
Asosiy maydon
SHE
Bozor yangiliklari
Investor's Business Daily
1 kun oldin
6 Under-The-Radar S&P 500 Stocks Quietly Recommended By Analysts
0,61%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,11 mlrd | 15,85% |
Joriy xarajat | 595,66 mln | 12,44% |
Sof foyda | 215,63 mln | 30,19% |
Sof foyda marjasi | 19,42 | 12,38% |
Har bir ulushga tushum | — | — |
EBITDA | 325,52 mln | 20,69% |
Amaldagi soliq stavkasi | 7,72% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,42 mlrd | 26,81% |
Jami aktivlari | 10,98 mlrd | 7,34% |
Jami passivlari | 2,05 mlrd | 29,25% |
Umumiy kapital | 8,93 mlrd | — |
Tarqatilgan aksiyalar | 1,11 mlrd | — |
Narxi/balansdagi bahosi | 6,66 | — |
Aktivlardan daromad | 5,45% | — |
Kapitaldan daromad | 6,52% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 215,63 mln | 30,19% |
Operatsiyalardan naqd pul | 351,03 mln | 9,40% |
Sarmoyadan naqd pul | -236,28 mln | 55,75% |
Moliyadan naqd pul | 24,83 mln | -91,95% |
Naqd pulning sof oʻzgarishi | 135,42 mln | 53,56% |
Boʻsh pul | -881,51 mln | 27,65% |
Haqida
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Tashkil etilgan
3-noy, 1998
Sayt
Xodimlar soni
3 596
